From: Emerging roles of circular RNAs in tumorigenesis, progression, and treatment of gastric cancer
No | CircRNA | Drugs or Others | Expression | Role in drug resistance | Molecular mechanism | Refs. |
---|---|---|---|---|---|---|
1 | hsa_circ_0081143 | Cisplatin | Upregulated | Enhancer | Sponge miR-646 to upregulate CDK6 | [65] |
2 | circDONSON | Cisplatin | Upregulated | Enhancer | Sponge miR-802 to upregulate BMI1 | [66] |
3 | circAKT3 | Cisplatin | Upregulated | Enhancer | Sponge miR-198 to upregulate PIK3R1 | [67] |
4 | circPVT1 | Cisplatin | Upregulated | Enhancer | Sponge miR-152-3p to upregulate HDGF | [68] |
5 | circARVCF | Cisplatin | Upregulated | Enhancer | Sponge miR-1205 to upregulate FGFR1 | [69] |
6 | circ-LDLRAD3 | Cisplatin | Upregulated | Enhancer | Sponge miR-588 to upregulate SOX5 | [70] |
7 | circ_0017274 | Cisplatin | Upregulated | Enhancer | Sponge miR-637 to upregulate CDX2 | [71] |
8 | circUBAP2 | Cisplatin | Downregulated | Suppressor | Sponge miR-300 to upregulate KAT6B | [72] |
9 | circVAPA | Cisplatin | Upregulated | Enhancer | Sponge miR-125b-5p to upregulate STAT3 | [73] |
10 | circCCDC66 | Cisplatin | Upregulated | Enhancer | Sponge miR-618 to upregulate BCL2 | [74] |
11 | circFN1 | Cisplatin | Upregulated | Enhancer | Sponge miR-182-5p | [75] |
12 | circ_0000260 | Cisplatin | Upregulated | Enhancer | Sponge miR-129-5p to upregulate MMP11 | [76] |
13 | circCUL2 | Cisplatin | Downregulated | Suppressor | Sponge miR-142-3p to upregulate ROCK2 | [77] |
14 | circMCTP2 | Cisplatin | Downregulated | Suppressor | Sponge miR-99a-5p to upregulate MTMR3 | [78] |
15 | circHIPK3 | Cisplatin | Upregulated | Enhancer | Sponge miR-508-3p to upregulate BCL-2 | [79] |
16 | circSOD2 | Cisplatin | Upregulated | Enhancer | Sponge miR-1296 to upregulate STAT1 | [80] |
17 | circ-MTO1 | Oxaliplatin | Downregulated | Suppressor | - | [81] |
18 | circLRCH3 | Oxaliplatin | Upregulated | Enhancer | Sponge miR-383-5p to upregulate FGF7 | [82] |
19 | hsa_circ_0001546 | Oxaliplatin | Downregulated | Suppressor | Sponge miR-421 to upregulate ATM | [83] |
20 | circ_0032821 | Oxaliplatin | Upregulated | Enhancer | Sponge miR-515-5p to upregulate SOX9 | [84] |
21 | hsa_circ_0000144 | Oxaliplatin | Upregulated | Enhancer | Sponge miR-502-5p to upregulate ADAM9 | [85] |
22 | circMTHFD2 | Pemetrexed | Upregulated | Enhancer | Sponge miR-124 to upregulate MDR-1 | [86] |
23 | circ-PVT1 | Pemetrexed | Upregulated | Enhancer | Sponge miR-124-3p/ to upregulate ZEB1 | [87] |
24 | circCPM | 5-FU | Upregulated | Enhancer | Sponge miR-21-3p to upregulate PRKAA2 | [88] |
25 | circNRIP1 | 5-FU | Upregulated | Enhancer | Sponge miR-138-5p to upregulate MDR-1 | [89] |
26 | circPRRX1 | radiation | Upregulated | Enhancer | Sponge miR-596 to upregulate NKAP | [90] |
27 | circDLG1 | anti-PD-1 | Upregulated | Enhancer | Sponge miR-141-3p to upregulate CXCL12 | [91] |
28 | hsa_circ_0000520 | Herceptin | Downregulated | Suppressor | Inhibiting PI3K-Akt signaling pathway | [92] |